发明名称 |
FGF21 mutants and uses thereof |
摘要 |
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such 5 nucleic acids, polypeptides, or pharmaceutical compositions. |
申请公布号 |
AU2016204968(A1) |
申请公布日期 |
2016.08.04 |
申请号 |
AU20160204968 |
申请日期 |
2016.07.15 |
申请人 |
AMGEN INC. |
发明人 |
BELOUSKI, EDWARD JOHN;ELLISON, MURIELLE MARIE;HAMBURGER, AGNES EVA;HECHT, RANDY IRA;LI, YUE-SHENG;MICHAELS, MARK LEO;SUN, JEONGHOON;XU, JING |
分类号 |
C07K14/50;A61K38/18 |
主分类号 |
C07K14/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|